All sites C00-96,D32-33,D42-43,D45-47,D76 487 86.9 5.4 3.6 0.7 3.4
Mouth, pharynx C00-14 14 98.6 1.4 - - -
  Lip C00 3 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 7 97.0 3.0 - - -
Digestive organs C15-26 101 79.6 5.9 6.7 2.0 5.7
  Oesophagus C15 6 93.5 - - - 6.5
  Stomach C16 13 98.4 - - - 1.6
  Small intestine C17 1 85.7 - - - 14.3
  Colon C18 26 95.5 - 0.8 - 3.8
  Rectum, rectosigmoid C19-20 22 99.1 - - 0.9 -
  Anus C21 0 100.0 - - - -
  Liver C22 9 50.0 19.6 23.9 - 6.5
  Gallbladder, bile ducts C23-24 6 69.0 17.2 10.3 - 3.4
  Pancreas C25 16 29.6 18.5 22.2 11.1 18.5
  Other digestive organs C26 1 25.0 25.0 25.0 - 25.0
Respiratory organs C30-39 68 67.2 22.6 8.2 0.6 1.5
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 4 100.0 - - - -
  Lung, trachea C33-34 62 64.8 24.5 8.4 0.6 1.6
  Mediastinum, pleura C38 1 - 33.3 66.7 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 16 100.0 - - - -
Skin, non-melanoma C44 22 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 3 92.9 - 7.1 - -
Breast C50 1 83.3 16.7 - - -
Male genital organs C60-63 132 99.1 - - - 0.9
  Prostate C61 129 99.1 - - - 0.9
  Testis C62 3 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 40 95.0 1.5 2.5 - 1.0
  Kidney C64 11 89.1 1.8 7.3 - 1.8
  Bladder and urinary tract2 C65-68 29 97.3 1.4 0.7 - 0.7
Eye C69 0 - - 100.0 - -
Brain, central nervous system C70-72,D32-33,D42-43 16 91.0 - 7.7 - 1.3
Thyroid gland C73 5 95.8 4.2 - - -
Other endocrine glands C74-75 1 75.0 - - - 25.0
Illdefined or unknown C76,C80 8 51.2 7.3 19.5 7.3 14.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 57 81.1 5.2 1.7 0.7 11.2
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 27 94.9 2.9 - - 2.2
  Malignant immunoproliferative diseases C88 1 85.7 - - - 14.3
  Myeloma and other plasma cell tumors C90 7 65.7 17.1 11.4 2.9 2.9
  Leukaemia C91-95 11 64.2 9.4 1.9 1.9 22.6
  Myelodysplastic syndromes D46 3 21.4 - - - 78.6
  Myeloproliferaitive neoplasms D45,D47 5 85.2 - - - 14.8
Not included above
  Basal cell carcinoma of the skin 145 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.